This HTML5 document contains 209 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1371/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34182308
rdf:type
wikibase:Item
schema:description
مقالهٔ علمی wetenschappelijk artikel 2012年学术文章 vetenskaplig artikel 2012年學術文章 scientific article artikull shkencor artigo científico (publicado na 2012) επιστημονικό άρθρο 2012年学术文章 artigo científico мақолаи илмӣ 2012年の論文 научная статья مقالة علمية نشرت بتاريخ 27-2-2012 wissenschaftlicher Artikel videnskabelig artikel (udgivet 2012) 2012年學術文章 tieteellinen artikkeli наукова стаття, опублікована в лютому 2012 2012年學術文章 научни чланак artículo científico publicado en 2012 mokslinis straipsnis vitskapeleg artikkel 2012年學術文章 teaduslik artikkel سائنسی مضمون artikulong pang-agham article scientific tudományos cikk artigo científico (publicado na 2012) articol științific vitenskapelig artikkel 2012年学术文章 2012 թվականի փետրվարին հրատարակված գիտական հոդված vedecký článok naučni članak article científic ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artykuł naukowy 2012年学术文章 научни чланак artículu científicu espublizáu en 2012 2012年学术文章 bài báo khoa học სამეცნიერო სტატია 2012 nî lūn-bûn научна статия 2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած bilimsel makale article scientifique (publié 2012) 2012年學術文章 articolo scientifico 2012年學術文章 scienca artikolo 2012년 논문 מאמר מדעי vědecký článek мақолаи илмӣ บทความทางวิทยาศาสตร์
p:P577
wds:Q34182308-7DC34991-A582-4241-9454-0F23713A4077
wdt:P577
2012-02-27T00:00:00Z
p:P407
wds:Q34182308-0021CE93-7E3B-4A0B-9C70-F97E19C024C7
wdt:P407
wd:Q1860
p:P2860
wds:Q34182308-01CE302E-139B-423E-995C-FD0471C3F2C5 wds:Q34182308-08B03DD6-FEDE-47D0-A382-304ACDA668B8 wds:Q34182308-0BD50A58-3376-481E-AA7C-45039FCB6A10 wds:Q34182308-22C91545-E4A2-490D-88C9-673DD74F37ED wds:Q34182308-274A699E-A0B3-496A-92FA-D6F22978DCE0 wds:Q34182308-124EE702-15F1-4A40-98F8-88A29DE29A34 wds:Q34182308-157FC0EE-285B-48DA-AA5F-BF03DD3F0925 wds:Q34182308-FC095616-EBC5-495D-AD5D-0C5A8C68E608 wds:Q34182308-FC44F2A4-8F52-46FD-80FD-7B54A55291EE wds:Q34182308-FCF50FB5-17DE-4B64-AA91-54696F4805A4 wds:Q34182308-E4D5903C-0412-4F61-9F92-5E0087C01A03 wds:Q34182308-FB0255D9-D23A-414F-A030-73F56B13D940 wds:Q34182308-FB500E60-02DC-4E84-899D-F4C29C4D99F4 wds:Q34182308-BEE9CBE2-BC8C-4BEF-A099-C89FF0C309BE wds:Q34182308-C1E23FF8-D4EC-4A8C-86C1-C45AAF7DA5FB wds:Q34182308-C4D084B2-4161-4410-A576-62CD9C029FC7 wds:Q34182308-AC9E4220-467A-4B85-81AE-68E3EEFDFBDC wds:Q34182308-B0B29ADB-1827-4682-9CE7-15D3A8797C1C wds:Q34182308-B2FEFB34-0F99-48B4-8956-B8994786D001 wds:Q34182308-DFA5F43B-CCFE-4D3F-B10D-052F4EFCEAC6 wds:Q34182308-E06F2950-725B-420D-8B5B-8C1B8FF65D0F wds:Q34182308-D87065E1-FD9B-4A98-8FCB-FA60E979C840 wds:Q34182308-DA03E7A4-E158-4B30-B947-6D2BB7F761BD wds:Q34182308-DABE431D-D6CC-4120-87F4-D88533C925F2 wds:Q34182308-8A32CD00-9F8E-4593-8190-4DC528294356 wds:Q34182308-95342478-9625-410F-A351-D51A83338887 wds:Q34182308-77F3EC8E-32A6-4011-8D7C-DFE539AFCB53 wds:Q34182308-7E3A45A9-B2D0-4B54-A355-AB3CFE302F64 wds:Q34182308-A799EA0E-B0D2-412A-87BE-92C3EF5C40FB wds:Q34182308-A99B8098-E863-4CB7-B486-0A5F0B4A391A wds:Q34182308-9EB8977C-1AF7-47FD-B052-DCFDA5117D9D wds:Q34182308-A50AD2CC-5B96-4022-8244-DDBE17B87E42 wds:Q34182308-513246BA-A214-4C0B-8CCC-8C4DC946D037 wds:Q34182308-41083E4E-F99E-4B55-9F22-5A3EECA3AE86 wds:Q34182308-4ACA69B7-CCE9-4F58-9212-FEF3E565B9D6 wds:Q34182308-66A0B7D4-BCA5-4CB7-8CD6-CF30BC281C01 wds:Q34182308-6D15DDEC-E2D8-482B-89BF-08AD52D28E24 wds:Q34182308-5AEB46C2-DFB4-40B1-AFC4-6D066EB817BB wds:Q34182308-6403AA5D-CE4F-49A5-A9D1-6D1AC888641A wds:Q34182308-66304995-8717-4743-9EB7-7F65B26283D3
wdt:P2860
wd:Q41736991 wd:Q39546197 wd:Q30481064 wd:Q41680537 wd:Q68804520 wd:Q35937747 wd:Q84077688 wd:Q40784164 wd:Q29616129 wd:Q41931033 wd:Q28301602 wd:Q39912679 wd:Q35128155 wd:Q33259359 wd:Q34766148 wd:Q41704578 wd:Q30825220 wd:Q36459332 wd:Q38430558 wd:Q44011532 wd:Q85119300 wd:Q43551866 wd:Q24644442 wd:Q40172789 wd:Q38332576 wd:Q40126702 wd:Q35782660 wd:Q73498630 wd:Q32054392 wd:Q24633445 wd:Q33960119 wd:Q53538423 wd:Q54451826 wd:Q24613307 wd:Q39716492 wd:Q35403688 wd:Q39966752 wd:Q29616128 wd:Q39695762 wd:Q80028110
p:P2093
wds:Q34182308-E0BF37FB-E159-44A8-9530-95130D36B6AA wds:Q34182308-E4A888B2-7CB0-4787-B261-FE1AE39D7D5D wds:Q34182308-E6D6E66C-8A04-4407-9405-B570032F2CC7 wds:Q34182308-4BC6528B-4318-450C-A73A-07B07B50B1F8 wds:Q34182308-5769E265-6966-4191-8385-06DBDF97CB56 wds:Q34182308-01ABAD10-6F04-418D-94E2-47E4E30AA9BE wds:Q34182308-7C327894-FF69-4EB8-92AF-57D749A9C1BE wds:Q34182308-9AD166DD-3892-448B-B60B-53D46A177687 wds:Q34182308-8FFE1F9A-A6D4-47A2-94DD-1D6DBE93AED1 wds:Q34182308-A1D4E60B-562A-4A61-A295-A3954BFEC2D8 wds:Q34182308-A5DA0CBA-52C5-448D-897A-DA8CD8B5ECBF wds:Q34182308-BCBBDD2D-08D8-4A7B-9878-81325C915A11
wdt:P2093
Seth M Pollack Eve Rodler Ernest U Conrad Elizabeth T Loggers Erik A Farrar Jeffrey Chou Janet F Eary Yonqing Li Benjamin L Hoch Cassian Yee Robin L Jones Megan J Blaisdell
rdfs:label
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine
skos:prefLabel
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine
schema:name
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine
p:P1476
wds:Q34182308-A3B5B029-3C30-4851-9042-0D7074F60841
wdt:P1476
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine
p:P304
wds:Q34182308-4CFE33F1-A0C8-4C17-80FE-3A96BCBBD5AD
wdt:P304
e32165
p:P31
wds:Q34182308-6E0DFE32-9249-4A29-AE32-E1CB853443ED
wdt:P31
wd:Q13442814
p:P921
wds:Q34182308-190D3141-AFA4-4486-8AD1-24A73F8F7694
wdt:P921
wd:Q1076087
p:P698
wds:Q34182308-D3E87CEC-4107-4FCC-B54F-F759B28B1B65
wdtn:P698
n10:22384167
wdt:P698
22384167
p:P1433
wds:Q34182308-47812F67-798B-4905-9C2A-7B19B55412A9
wdt:P1433
wd:Q564954
p:P433
wds:Q34182308-AB09B24B-AA16-404B-A8D9-CD5D9D231089
p:P478
wds:Q34182308-3519A361-5EE1-46BE-B8A7-7353B530E91E
wdt:P433
2
wdt:P478
7
p:P356
wds:Q34182308-3F5757EF-4899-4266-B239-5BEB137D2C9F
wdtn:P356
n8:JOURNAL.PONE.0032165
wdt:P356
10.1371/JOURNAL.PONE.0032165
p:P275
wds:Q34182308-128e911c-9a37-4f3f-b182-2f93a38721c2
p:P6216
wds:Q34182308-51d5b1f6-000a-45dc-aee9-fbbc24810cdc
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P5875
wds:Q34182308-67B6C30C-7B61-4016-9EF4-FD3DD574FB73
wdt:P5875
221882767
p:P819
wds:Q34182308-324B0883-769C-457B-83D2-BCBB3DC07B3E
wdt:P819
2012PLoSO...732165P
p:P932
wds:Q34182308-B54E393A-604D-4639-82D1-D25D90210777
wdt:P932
3288075